Skip to main content
Caplight Logo









CDx Diagnostics

CDx Diagnostics

Private
Suffern, New YorkHealthcare & Life Scienceshttps://www.cdxdiagnostics.com/

Last Round

VC Round

Dec 1, 2019

Total Funding Raised

$60M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

CDx Diagnostics is a healthcare company that provides specialized anatomic pathology laboratory services and AI-powered diagnostic technology for the early detection of precancerous and cancerous tissue.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Medical Imaging

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

anatomic pathologyWATS3Ddigital pathologyprecancerous detectionpathology labbrush biopsyesophageal cancer screeningAI diagnosticsAI pathologycancer screening techCLIA-certified laboratoryCAP-accreditedcytologyimmunohistochemistryhistology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CDx Diagnostics Comparables

Compare CDx Diagnostics with similar companies based on industry and business-model similarity.

CDx Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Lucid Diagnostics Inc.
78%
Castle Biosciences, Inc.
77%
ProPhase Labs Inc
71%

CDx Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundDec 1, 2019
Private EquityJul 11, 2017
DebtJul 11, 2017

Key People

Founding team and executive leadership

Mark Rutenberg

Founder and Chief Scientific Officer, Founder

Founding Team

Edward Yom

Senior Vice President, Chief Technology Officer

Executive Team

CDx Diagnostics Investors

Notable investors and investment history

CDx Diagnostics investors
InvestorRounds
Galen PartnersPrivate Equity
White Oak Healthcare FinanceDebt

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 29, 2026

    Monthly visitors increased 78% MoM.

  • Apr 8, 2026

    Monthly visitors increased 47% MoM.

CDx Diagnostics Filings

Explore SEC and related filing metadata, where available.

CDx Diagnostics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CDx Diagnostics's valuation, stock price, and market status.

Is CDx Diagnostics a public or private company?

CDx Diagnostics is a private company.

What is the current stock price of CDx Diagnostics?

CDx Diagnostics is a private company with no public stock price. No recent secondary market data is available.

How much is CDx Diagnostics worth (valuation)?

Valuation information for CDx Diagnostics is not publicly available.

Can I buy CDx Diagnostics stock?

CDx Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was CDx Diagnostics's last funding round?

CDx Diagnostics's most recent funding round was VC Round on December 1, 2019.

Who are the main investors in CDx Diagnostics?

Key investors in CDx Diagnostics include Galen Partners, White Oak Healthcare Finance.

Will CDx Diagnostics IPO soon?

No public IPO plans have been announced for CDx Diagnostics.

How can I track CDx Diagnostics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CDx Diagnostics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSuffern, New York
Employee Range75
Year Founded1997
Last FundingDec 1, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?